These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2672269)

  • 1. [Treatment of the gynecologic consequences of hyperandrogenism].
    Buvat J; Buvat-Herbaut M
    Rev Fr Gynecol Obstet; 1989 Jun; 84(6):513-22. PubMed ID: 2672269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary forms of polycystic ovary syndrome.
    Kaltsas GA; Isidori AM; Besser GM; Grossman AB
    Trends Endocrinol Metab; 2004 Jul; 15(5):204-10. PubMed ID: 15223049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sex hormones and the skin].
    Boukhris R
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(7):831-42. PubMed ID: 2693519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [When and why should hyperandrogenism be searched for in women?].
    Buvat J
    Rev Fr Gynecol Obstet; 1989 Jun; 84(6):483-8. PubMed ID: 2672267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Colpocytologic investigation in syndromes of female hyperandrogenism].
    Cantiello L; De Luca F; Morgera L
    Rass Int Clin Ter; 1972 May; 52(9):547-54. PubMed ID: 5030097
    [No Abstract]   [Full Text] [Related]  

  • 6. Adrenal disorders and polycystic ovary syndrome.
    Dunaif A
    Horm Res; 1992; 37 Suppl 3():39-44. PubMed ID: 1427640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of dermatologic manifestations of hyperandrogenism].
    Beylot C
    Rev Fr Gynecol Obstet; 1989 Jun; 84(6):523-9. PubMed ID: 2528200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
    Nardo LG; Patchava S; Laing I
    Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possible alternative to the corticoid treatment of hyperandrogenic endocrine diseases with ovulation inhibitors].
    Musso G; Pacilli L
    Minerva Ginecol; 1967 Jan; 19(1):27-30. PubMed ID: 4299288
    [No Abstract]   [Full Text] [Related]  

  • 10. [Synthesis and secretion of ovarian steroid hormones in polycystic ovary syndrome].
    Vasiljević M; Prorocić M; Antić N; Garelejić E; Rakić S; Tasić L; Arsić B; Maglić R
    Srp Arh Celok Lek; 2000; 128(11-12):397-402. PubMed ID: 11337921
    [No Abstract]   [Full Text] [Related]  

  • 11. The evaluation and treatment of androgen excess.
    Practice Committee of the American Society for Reproductive Medicine
    Fertil Steril; 2006 Nov; 86(5 Suppl 1):S241-7. PubMed ID: 17055833
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of insulin sensitizers in polycystic ovarian syndrome.
    Baillargeon JP
    Curr Opin Investig Drugs; 2005 Oct; 6(10):1012-22. PubMed ID: 16259222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T; Dehghan-Kooshkghazi M
    Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgens and polycystic ovary syndrome.
    Nisenblat V; Norman RJ
    Curr Opin Endocrinol Diabetes Obes; 2009 Jun; 16(3):224-31. PubMed ID: 19390322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovary syndrome.
    Chihal HJ; Baudier MM
    Am Fam Physician; 1985 Apr; 31(4):159-65. PubMed ID: 3157301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epilepsy and disorders of reproduction].
    Dravecká I; Lazúrová I
    Vnitr Lek; 2007 Jan; 53(1):46-53. PubMed ID: 17472015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term consequences of polycystic ovary syndrome on cardiovascular risk.
    Rizzo M; Berneis K; Spinas G; Rini GB; Carmina E
    Fertil Steril; 2009 Apr; 91(4 Suppl):1563-7. PubMed ID: 18976752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment options of polycystic ovary syndrome in adolescence.
    Zapanti E; Kiapekou E; Loutradis D
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():208-13. PubMed ID: 16641862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin and related peptides in hyperandrogenism.
    Adashi EY
    Clin Obstet Gynecol; 1991 Dec; 34(4):872-81. PubMed ID: 1778029
    [No Abstract]   [Full Text] [Related]  

  • 20. Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome.
    Genazzani AD; Strucchi C; Luisi M; Casarosa E; Lanzoni C; Baraldi E; Ricchieri F; Mehmeti H; Genazzani AR
    Gynecol Endocrinol; 2006 Jan; 22(1):36-43. PubMed ID: 16522532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.